Erasca Inc

Erasca Inc. is a clinical-stage precision oncology company based in San Diego, dedicated to transforming cancer treatment by targeting the RAS MAPK pathway, which is commonly mutated in various cancers affecting millions globally each year. With a robust and modality-agnostic pipeline, Erasca aims to make a significant impact on the lives of patients through innovative therapeutic programs designed to shut down this critical signaling cascade.

Founded in 2018 by Jonathan E. Lim, M.D., Erasca is driven by a mission to erase cancer and is committed to combining serious scientific research with an engaging corporate culture. The company's leadership brings extensive experience in biotechnology and drug delivery, with a proven track record of achieving global regulatory approvals and advancing precision oncology initiatives.

Generated from the website